Vesicular stomatitis virus (VSV) provides an example of a viral system exhibiting homologous interference mediated by defective particles (6) . This interference occurs intracellularly and results in an inhibition of the growth of plaque-forming, standard B particles (2, 5, 9) . Interference is detected only if defective particles are added before the first half of the growth cycle of standard virus (10) . This suggests that the inhibition occurs at an early step during viral replication. All the virus-specific events, such as ribonucleic acid (RNA) synthesis (20) and protein synthesis (12, 15, 22) occur within the first 3 hr after viral penetration. It is not known which of these functions is primarily inhibited by defective particles. Total viral protein synthesis is reduced when defective particles are added early during the replication of B particles, but the pattern of viral polypeptides is not altered (15, 22) . When total viral RNA synthesis is examined, interference by defective particles results in an overall decrease of RNA synthesis and a change in the pattern of RNA species which are synthesized (20) .
VSV RNA synthesis can be divided into two distinct kinds: one which results in the synthesis of multiple pieces of messenger RNA complementary to virion RNA (8, 14) and another which results in production of progeny virion RNA. The latter synthesis, called RNA replication as opposed to transcription, is at present not understood in detail. Nevertheless, it is now possible to examine the effect of defective particles on viral RNA synthesis in some detail because intracellular viral transcription by input virions can be studied in the absence of viral replication. The finding of a virion-associated RNA polymerase in VSV (1) suggested that early viral transcription would occur in cells in the absence of any other viral replicative steps if cells were treated at the beginning of infection with an inhibitor of protein synthesis (18, 23) . Such a system to study early transcription by VSV has been described (13) . The results presented here show the early transcription in VSV-infected Chinese hamster ovary (CHO) cells catalyzed by the MATERIALS AND METHODS Viruses and cells. Growth of the Indiana serotype of VSV in CHO cells has been previously described (20) . Purified preparations of standard B particles of VSV completely free of defective virions were obtained by clonal isolation (21) and found to contain 4 X 109 to 8 X 109 plaque-forming-units (PFU)/ml by assay on CHO cells (21) . One preparation of defective particles (9) was used throughout these experiments. It was prepared in chick embryo fibroblasts (9) and purified (21) as previously described. The preparation was estimated to contain approximately 4 X 108 active particles/ml by assuming that the number of active particles in 1 optical density at 269 nm (OD260) unit of T particles is equal to three times the number of PFU contained in 1 OD260 unit of standard virus. This adjustment is based on the fact that T particles contain one-third the amount of RNA of standard virions (11) and that the effective infectivity to particle ratios of the two particles are assumed to be approximately the same. Contamination of this T particle preparation by standard virions was no greater than 6.80 X 108 PFU/ml.
Protocol for infections. In general, infections were carried out as previously described (8) of the 28S and 13 to 15S RNA species synthe-treated with 100 ,ug ofcycloheximide per ml and labeled sized in the presence of cycloheximide and with 100 MCi of 3H-uridine per ml. At 3 hr after infeclabeled with 3H-uridine from 0.5 hr to 3 hr after tion the cells were harvested and the cytoplasmic RNA infection. No RNA species sedimenting faster separated on sucrose gradients containing 0.01% sothan 28S was detected either in the gradient or dium dodecyl sulfate. After centrifugation hlalf of each in the pellet fraction of the centrifuge tube fraction was digested with ribonuclease and the RNA inWthen pellefthfractionsof theacentri witub acid precipitated as previously described (10) . (0 (Fig. 3) , indicating that 28S and 13 to 15S RNA species were single stranded.
Annealing of this labeled RNA made in the presence of cycloheximide to excess unlabeled virion RNA showed that the intracellular RNA was almost completely (97 %) complementary in base sequence to virion RNA (Table 1) . Also, when 3H-adenosine-labeled virion RNA was annealed to excess cytoplasmic RNA from in- fected cells treated with cycloheximide all of the virion RNA became ribonuclease-resistant, whereas virion RNA alone labeled with 3H-adenosine was completely ribonuclease sensitive (Table 1) . These results indicate that in the presence of cycloheximide only RNA complementary to virion RNA was transcribed intracellularly and that the virion RNA was transcribed completely.
Absence of newly synthesized nucleocapsids in the presence of cycloheximide. To demonstrate that no nucleocapsids containing 28S RNA were synthesized in the presence of cycloheximide the uridine-labeled ribonucleoproteins made by VSV in the presence or absence of cycloheximide were separated in sucrose gradients containing ethylenediaminetetraacetate. In the absence of cycloheximide there were three major RNA-containing species which have been previously identified as either nucleocapsids at 120S or messenger ribonucleoproteins at 65S and 30S (8) . In the presence of cycloheximide only, the two messenger ribonucleoprotein species were detected (Fig. 4) . The absence of any newly synthesized nucleocapsids in cycloheximide-treated cells further indicated that the RNA synthetic activity was indeed viral transcription and most likely due to the virion-associated transcriptase (1).
Temperature optimum for intracellular VSV transcription. Because the in vitro VSV polymerase reaction has a temperature optimum of 31 C (7), the temperature optimum was determined for the intracellular transcriptase activity. Figure 5 shows that the intracellular activity occurred best at 34 to 37 C and not at 31 C.
Similarly, total viral RNA synthesis in the absence of cycloheximide occurred optimally at 34 to 37 C and not at 31 C (E. K. Manders, unpublished observations).
Effect of T particles on transcription. To determine if defective (T) particles could directly inhibit the intracellular transcriptase activity associated with input standard B particles, an approximately equivalent concentration of T and B particles was added to CHO cells immediately after the addition of cycloheximide. For comparison, the same concentration of T and B particles was added to CHO cells which were not treated with cycloheximide. Although in this experiment T inhibited the growth of plaqueforming B particles by more than 99% and total 14C-uridine incorporation by about 90% (Fig.   6b) , none of the incorporation in the presence of cycloheximide was affected by the presence of T particles (Fig. 6a) . This To further rule out the contribution of RNA synthesis directed by T particles in cycloheximidetreated cells, the labeled RNA from an experiment similar to the one shown in Fig. 6 was deproteinized and examined on sucrose gradients containing sodium dodecyl sulfate. Viral RNA in the cycloheximide-treated cells had almost identical patterns whether the cells were infected with B alone or with both B and T particles (Fig. 7a) . The control patterns from infected cells not treated with the inhibitor show the usual pattern of total RNA synthesis by B alone and the dramatic shift to T particle-directed RNA synthesis when T was added to cells together with B particles (Fig. 7b; cf. 20) .
Effect of prior incubation of T particles on transcription. To (0); infected with B particles polymerase activity (4) (19) finding that RNA alone, extracted from T particles, causes interference suggests that viral structural proteins of T particles are unnecessary. Because of these findings it appears likely that T particles interfere at the step of viral RNA replication by competing successfully for replicative enzymes. Such an idea has been proposed previously (20) and the lack of effect of T particles on early transcription by B particles supports that hypothesis. Moreover, studies on another system, Sendai virus, show that defective particles added late in the viral growth cycle preferentially inhibit the synthesis of virion RNA rather than messenger RNA (16) . To prove that homologous interference in these two systems is the result of competition for replicative enzymes requires an understanding of the enzyme(s) and template(s) involved during the replication of virion RNA.
The lack of inhibition of early transcription by defective particles, together with the finding that T particles interfere in the presence of actinomycin D, shows that inhibition by defective particles, at least in the rhabdovirus and paramyxovirus groups, is a distinct interference phenomenon and not in any way mediated through the induction of interferon. This points to the differential site of action between the interference induced by homologous defective particles and the interference induced by interferon. Recently, Marcus et al. (13) showed that chick cells pretreated with interferon do not support transcription by VSV as well as untreated cells. By using human muscle skin fibroblasts, similar results have been obtained (Manders, Tilles, and Huang; manuscript in preparation).
In comparing intracellular to in vitro VSV RNA synthesis there are several points to note. In addition to the temperature optimum, intracellular transcription results in 28S and 13 to 15S species of messenger RNA, whereas in vitro RNA synthesis makes only single-stranded RNA smaller than 15S whether the synthesis is accomplished by purified virions (3, 7) or by partially purified nucleocapsid fractions from infected cells (L. Prevec, personal communication). Despite complementarity of the in vitro RNA products to virion RNA (1) and the almost complete transcription of virion RNA by the enzyme (3), the in vitro polymerase reaction does not adequately represent early intracellular transscription during the course of VSV replication. 
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Until it is understood why the in vitro products differ in size from the intracellular messenger RNA, observations made on the in vitro polymerase assay can be extended to viral replication only with caution.
The annealing data presented here lead to several interesting conclusions aside from demonstrating that RNA made in the presence of cycloheximide was complementary to virion RNA. When virion RNA was labeled with 3H-adenosine and digested with ribonucleases A and TI, essentially no ribonuclease-resistant core was detected. This indicates that virion RNA contains no long sequences of poly A, whereas digestion of 3H-adenosine-labeled 13 to 15S messenger RNA of VSV showed that these RNA species contained poly A sequences which represented about 25 %7 of the total 3H-adenosine incorporated into the RNA (Soria and Huang, unpublished observations). The presence of poly A in VSV messenger RNA has been suggested by the base composition studies of Mudd and Summers (14) . It should be possible to study the function of poly A by using the VSV system where the virion RNA, lacking poly A, serves as a template for the synthesis of messenger RNA which contains poly A.
Another conclusion from these annealing studies is that the genome of VSV appears to be completely transcribed intracellularly by the virion-associated enzyme. It would be safe to generalize for viruses which carry the RNAdependent transcriptase as part of virions that the first synthetic event after uncoating is copying of the complete viral genome into multiple, complementary messenger RNA species.
